{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "7061212", "DateCompleted": {"Year": "1982", "Month": "05", "Day": "21"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0146-0404", "JournalIssue": {"Volume": "22", "Issue": "3", "PubDate": {"Year": "1982", "Month": "Mar"}}, "Title": "Investigative ophthalmology & visual science", "ISOAbbreviation": "Invest Ophthalmol Vis Sci"}, "ArticleTitle": "Crosslinking and photoreaction of ozone-oxidized calf-lens alpha-crystallin.", "Pagination": {"StartPage": "402", "EndPage": "405", "MedlinePgn": "402-5"}, "Abstract": {"AbstractText": ["Direct-photo-oxidation, singlet oxygen-oxidation, or photosensitized oxidation can modify lens crystallins, causing an increase in blue fluorescence and covalent crosslinking. A relationship between these changes has not been elucidated. We now report results from experiments with ozone oxidation. When calf-lens alpha-crystallin is treated with zone oxidation. When calf-lens alpha-crystallin is treated with ozone, new absorption, fluorescence, and phosphorescence, which are characteristic of the oxidized product of tryptophan (N-formylkynurenine), appear at 320, 435, and 445 nm, respectively. In addition, in this ozonization of alpha-crystallin, its polypeptides are crosslinked by nondisulfide bonds. Irradiation of ozone-treated alpha-crystallin with near-ultraviolet (365 nm) light increases crosslinking and reduces the 320 nm absorbance with a concomitant appearance of a new absorption at about 420 nm. This photoproduct exhibits an intense fluorescence around 450 nm and a weak phosphorescence at 510 nm, with excitation peaks at 400, 415, and 422 nm. These findings are essentially the same as those observed in photo-oxidized alpha-crystallin, suggesting the involvement of the same tryptophan oxidized product in the modification of the lens protein."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Fujimori", "ForeName": "E", "Initials": "E"}], "GrantList": [{"GrantID": "EY 01810", "Acronym": "EY", "Agency": "NEI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Invest Ophthalmol Vis Sci", "NlmUniqueID": "7703701", "ISSNLinking": "0146-0404"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Crystallins"}, {"RegistryNumber": "1022-31-7", "NameOfSubstance": "N'-formylkynurenine"}, {"RegistryNumber": "343-65-7", "NameOfSubstance": "Kynurenine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cattle"}, {"QualifierName": ["analysis", "radiation effects"], "DescriptorName": "Crystallins"}, {"QualifierName": [], "DescriptorName": "Fluorescence"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["analogs & derivatives", "analysis"], "DescriptorName": "Kynurenine"}, {"QualifierName": ["analysis", "drug effects"], "DescriptorName": "Lens, Crystalline"}, {"QualifierName": [], "DescriptorName": "Light"}, {"QualifierName": [], "DescriptorName": "Luminescent Measurements"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Photochemistry"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1982", "Month": "3", "Day": "1"}, {"Year": "1982", "Month": "3", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1982", "Month": "3", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7061212"]}}], "PubmedBookArticle": []}